PHI with Altered plasma viscosity
How does this condition affect your private health insurance?
Altered plasma viscosity refers to a change in the thickness or resistance to flow of the blood plasma. It is not a primary disease but rather a laboratory finding indicative of underlying conditions. Increased viscosity (hyperviscosity) can significantly impair blood flow, especially in microcirculation, leading to reduced oxygen delivery to tissues. Common causes include elevated levels of proteins (e.g., immunoglobulins in conditions like multiple myeloma or Waldenström's macroglobulinemia), severe inflammation, and extreme dehydration. Symptoms can include visual disturbances, neurological changes, and an increased risk of thrombosis. Its management focuses on treating the root cause.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 10%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Varies widely, from acute onset (e.g., severe dehydration) to insidious development over months or years (e.g., chronic inflammatory conditions or monoclonal gammopathies).
Duration of Illness (Lifetime)
Can be transient if the underlying cause is acute and treatable, or chronic if associated with lifelong conditions like certain autoimmune diseases or hematological malignancies requiring ongoing management.
Cost of Treatment (Initial)
Initial costs involve diagnostics for the underlying cause (blood tests, imaging) and potentially acute interventions like plasmapheresis; can range from hundreds to several thousands of Euros, depending on the complexity of the diagnosis and immediate management.
Cost of Treatment (Lifetime)
Highly variable, from negligible for transient causes to tens of thousands or even hundreds of thousands of Euros for chronic management of underlying diseases like multiple myeloma or autoimmune disorders, including regular monitoring and specific therapies.
Mortality Rate
Not directly from altered viscosity itself, but reflects the severity of its underlying causes. For severe underlying conditions (e.g., advanced multiple myeloma, severe autoimmune vasculitis), it can be substantial (20-80%) due to complications like thrombosis or organ failure.
Risk of Secondary Damages
High (50-90%) if left untreated or if the underlying cause is severe, including increased risk of thrombosis (stroke, heart attack), impaired microcirculation leading to organ damage, and symptoms like visual disturbances or neurological deficits.
Probability of Full Recovery
Depends entirely on the underlying cause. If the cause is reversible (e.g., dehydration), recovery is high (>90%). For chronic or incurable underlying diseases, complete recovery of normal viscosity without ongoing treatment is low (5-20%).
Underlying Disease Risk
100%, as altered plasma viscosity is a manifestation or symptom of another condition, not a primary disease itself. Common underlying causes include multiple myeloma, Waldenström's macroglobulinemia, inflammatory diseases, severe dehydration, and autoimmune disorders.